REGENERON PHARMACEUTICALS, INC. (REGN)
Clinical trial NCT02651662 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-31 → 2026-04-29 3. primary completion date: 2026-05-31 → 2026-04-29
Clinical trial NCT02651662 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-31 → 2026-04-29 3. primary completion date: 2026-05-31 → 2026-04-29
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical